LeBlanc R, Hollmann S, Tay J. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. J Popl Ther Clin Pharmacol. 2018;23(1). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/237